α-Glucosidase-IN-19
α-Glucosidase-IN-19 (Compound 6B) is a potent, orally active α-glucosidase inhibitor with an IC50 of 3.63 μM. α-Glucosidase-IN-19 shows anti-diabetic activity.
For research use only. We do not sell to patients.
- Formula: C31H25NOS
- Molecular Weight:459.60
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vivo
α-Glucosidase-IN-19 (10 and 20 mg/kg; p.o.; once) significantly decreases the serum glucose level after the administration of glucose (3 g/kg, oral) in rats[1].
α-Glucosidase-IN-19 (2000 mg/kg; p.o.; daily, for 2 weeks) demonstrates no mortality in mice[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male Wistar albino rats (170-200 g), Streptozotocin-induced diabetes model[1]
-
Dosage:10 and 20 mg/kg
-
Administration:Oral administration; daily, for 4 weeks
-
Result:Decreased the level of blood glucose, reversed Streptozocin-induced body weight loss. Showed antihyperlipidemic effects on Streptozotocin-induced diabetes, reduced to a significant level of serum biomarkers.
Chemical Information
-
Molecular Weight 459.60
-
Formula C31H25NOS
-
SMILES
CC1=CC=C(C=C1)C2=NC3=C(SC(C2)C4=CC=C(C=C4)/C=C/C(C5=CC=CC=C5)=O)C=CC=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)